Showing results (21-30 of 137) with videos related to

Sort By:
Pageof 14
The Journal of Infectious Diseases|March 14, 1998
In vivo synthesis of tumor necrosis factor-alpha in healthy humans after live yellow fever vaccinationU T Hacker, T Jelinek, S Erhardt, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 15, 1998
Spontaneous and cationic lipid-mediated uptake of antisense oligonucleotides in human monocytes and lymphocytesG Hartmann, A Krug, M Bidlingmaier, et al.
Gut|May 1, 1997
Lack of association between an interleukin-1 receptor antagonist gene polymorphism and ulcerative colitisU T Hacker, M Gomolka, E Keller, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 1999
Specific type IV phosphodiesterase inhibitor rolipram mitigates experimental colitis in miceG Hartmann, C Bidlingmaier, B Siegmund, et al.
Gut|March 31, 2007
Dendritic cell-based vaccination combined with gemcitabine increases survival in a murine pancreatic carcinoma modelC Bauer, F Bauernfeind, A Sterzik, et al.
Chest|October 1, 1996
The clinical relevance of circulating tumor necrosis factor-alpha in acute decompensated chronic heart failure without cachexiaR V Milani, M R Mehra, S Endres, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 4, 2001
Shock waves: a novel method for cytoplasmic delivery of antisense oligonucleotidesK Tschoep, G Hartmann, R Jox, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|September 15, 2001
Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha productionB Siegmund, G Fantuzzi, F Rieder, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2000
Enhanced dendritic cell maturation by TNF-alpha or cytidine-phosphate-guanosine DNA drives T cell activation in vitro and therapeutic anti-tumor immune responses in vivoC Brunner, J Seiderer, A Schlamp, et al.
European Journal of Clinical Investigation|May 6, 1998
Inflammatory bowel disease: no association between allele combinations of the interleukin (IL) I beta and IL-I receptor antagonist gene polymorphismsU T Hacker, C Bidlingmaier, M Gomolka, et al.
Pageof 14